Pivlaz clazosentan: Phase III started

ATLN began the double-blind, international Phase III CONSCIOUS-2 trial to compare 5 mg/hour Pivlaz vs. placebo in >765 patients who have had their aneurysm secured via surgery. The milestone triggers ...